Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03720899 · ClinicalTrials.gov registry record · Phase 2
Comparing NicoBloc to Nicotine Lozenges
A Phase 2 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT03720899: Completed Phase 2 study, sponsored by University of Alabama at Birmingham.
NCT03720899 is a Phase 2 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 45 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03720899, a Phase 2 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
To examine the feasibility, acceptability, and preliminary impact of using NicoBloc compared to nicotine lozenges
Primary Outcome
* Number of items: 10 * Scale: 1 (not at all helpful) - 7 (very helpful), as well as "0" response for "Don't Know". * Full-scale range: 0-70 * Interpretation: Higher scores indicate more treatment satisfaction Subscales: N/A
Interventions
- DRUG Nicotine Lozenge
- DRUG NicoBloc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-03-21 |
| Est. Completion | 2021-03-03 |
| Phase | Phase 2 |
What the finished NCT03720899 record still lists
NCT03720899 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 2 interventions - of which Nicotine Lozenge is the first listed.
NCT03720899 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03720899 about?
NCT03720899 is a clinical study titled "Comparing NicoBloc to Nicotine Lozenges". To examine the feasibility, acceptability, and preliminary impact of using NicoBloc compared to nicotine lozenges
What is the current status of trial NCT03720899?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2019-03-21. Estimated completion is 2021-03-03.
What interventions are being tested in trial NCT03720899?
The interventions under investigation include: Nicotine Lozenge (DRUG), NicoBloc (DRUG).
Who is sponsoring clinical trial NCT03720899?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03720899's enrollment target sits among peer trials
45 1296th of 2000 higher than 679 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI